Treatment costs → CAR-T Cell Therapy Cost

Cell-therapy pricing

CAR-T Cell Therapy Cost in Germany for International Patients

Understand why CAR-T treatment requires an individualized German hospital quotation and which clinical and logistical components can materially affect the total cost.

By Treat in Germany Editorial TeamSources reviewed: 2026-08-29Independent clinician review: not yet claimed
Cost answer: A single generic CAR-T price is not a safe basis for medical-travel budgeting. The total episode can include eligibility assessment, leukapheresis, cell-product manufacturing, bridging treatment, lymphodepleting chemotherapy, infusion, prolonged inpatient monitoring and treatment of serious complications. Charité's international-patient process states that the hospital provides a cost estimate for the expected stay after specialist review and requests upfront payment before admission.

Why an individual hospital estimate comes first

For international self-paying patients, a useful German quotation is normally prepared only after the medical records have been reviewed and the responsible clinical team has defined the expected treatment. The estimate may require advance payment and is later reconciled against the services actually delivered.

  • Medical-record review
  • Defined clinical treatment plan
  • Written cost estimate
  • Advance payment when required
  • Monitoring of additional services
  • Final invoice after treatment

CAR-T is a multi-stage treatment episode

The cost cannot be understood as the infusion alone. The clinical pathway may span several weeks and can change if the disease progresses, bridging therapy is needed, manufacturing is delayed or complications require intensive treatment.

Components that can materially affect the total

A quotation should be read together with the treatment plan.

  • Eligibility diagnostics and pathology review
  • Leukapheresis
  • Cell-product manufacturing
  • Bridging therapy when required
  • Lymphodepleting chemotherapy
  • CAR-T infusion
  • Inpatient monitoring
  • Management of cytokine-release syndrome or neurological toxicity
  • Follow-up blood tests, imaging and specialist visits

Ask what happens if the planned pathway changes

International patients should ask how additional hospital days, intensive care, unexpected medicines or a change in eligibility are handled financially. A preliminary estimate cannot guarantee that the original total will equal the final invoice.

Budget for the required stay near the treatment center

CAR-T programs may require the patient to remain close to the specialist center after infusion. Accommodation and companion costs can therefore be substantial even when they sit outside the hospital invoice.

Official sources

Sources last checked 2026-08-29.

Cost information notice: No universal German CAR-T price is presented here. The final amount depends on the patient-specific clinical pathway and the services actually delivered. Request a written estimate from the treating center after specialist review.
Send treatment request